[PHARMA] QoQ TTM Result on 30-Sep-2012 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
06-Nov-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
30-Sep-2012 [#3]
Profit Trend
QoQ- 21.5%
YoY- 114.93%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 1,846,836 1,865,940 1,812,346 1,697,728 1,642,700 1,582,398 1,520,981 13.82%
PBT 79,270 97,283 103,314 115,434 102,587 94,349 73,186 5.47%
Tax -29,878 -37,985 -40,108 -32,578 -34,308 -28,102 -20,401 28.99%
NP 49,392 59,298 63,206 82,856 68,279 66,247 52,785 -4.33%
-
NP to SH 47,949 57,797 61,711 81,587 67,151 65,358 52,157 -5.45%
-
Tax Rate 37.69% 39.05% 38.82% 28.22% 33.44% 29.79% 27.88% -
Total Cost 1,797,444 1,806,642 1,749,140 1,614,872 1,574,421 1,516,151 1,468,196 14.45%
-
Net Worth 480,568 484,829 472,037 496,469 481,394 474,161 514,153 -4.40%
Dividend
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Div 41,172 41,189 41,188 64,713 52,948 44,120 35,296 10.82%
Div Payout % 85.87% 71.27% 66.74% 79.32% 78.85% 67.51% 67.67% -
Equity
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Net Worth 480,568 484,829 472,037 496,469 481,394 474,161 514,153 -4.40%
NOSH 258,370 117,676 117,715 117,646 117,700 117,657 117,655 69.02%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin 2.67% 3.18% 3.49% 4.88% 4.16% 4.19% 3.47% -
ROE 9.98% 11.92% 13.07% 16.43% 13.95% 13.78% 10.14% -
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
RPS 714.80 1,585.65 1,539.60 1,443.07 1,395.66 1,344.91 1,292.74 -32.65%
EPS 18.56 49.11 52.42 69.35 57.05 55.55 44.33 -44.06%
DPS 15.94 35.00 35.00 55.00 44.99 37.50 30.00 -34.42%
NAPS 1.86 4.12 4.01 4.22 4.09 4.03 4.37 -43.44%
Adjusted Per Share Value based on latest NOSH - 117,646
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
RPS 128.14 129.47 125.75 117.80 113.98 109.80 105.53 13.83%
EPS 3.33 4.01 4.28 5.66 4.66 4.53 3.62 -5.41%
DPS 2.86 2.86 2.86 4.49 3.67 3.06 2.45 10.87%
NAPS 0.3334 0.3364 0.3275 0.3445 0.334 0.329 0.3567 -4.40%
Price Multiplier on Financial Quarter End Date
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Date 28/06/13 29/03/13 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 -
Price 4.49 8.26 8.10 7.55 10.18 5.90 5.36 -
P/RPS 0.63 0.52 0.53 0.52 0.73 0.44 0.41 33.19%
P/EPS 24.19 16.82 15.45 10.89 17.84 10.62 12.09 58.85%
EY 4.13 5.95 6.47 9.19 5.60 9.42 8.27 -37.08%
DY 3.55 4.24 4.32 7.28 4.42 6.36 5.60 -26.22%
P/NAPS 2.41 2.00 2.02 1.79 2.49 1.46 1.23 56.64%
Price Multiplier on Announcement Date
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Date 16/08/13 15/05/13 18/02/13 06/11/12 08/08/12 03/05/12 22/02/12 -
Price 4.66 9.26 7.80 8.25 8.83 5.90 5.90 -
P/RPS 0.65 0.58 0.51 0.57 0.63 0.44 0.46 25.94%
P/EPS 25.11 18.85 14.88 11.90 15.48 10.62 13.31 52.73%
EY 3.98 5.30 6.72 8.41 6.46 9.42 7.51 -34.53%
DY 3.42 3.78 4.49 6.67 5.09 6.36 5.08 -23.20%
P/NAPS 2.51 2.25 1.95 1.95 2.16 1.46 1.35 51.26%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment